Elevating Care in Resectable Stage I-III NSCLC: Targeted Therapy and Immunotherapy at the Forefront of Multimodal Treatment Strategies
Chair and Presenters Roy S. Herbst, MD, PhD, Tina Cascone, MD, PhD, and Tetsuya Mitsudomi, MD, PhD, ...
89 slides
38
Healthcare
PeerView